CME Group Inc.
NASDAQCME Group heads into its May 14 Q1 results with the stock under pressure, analyst targets moving in conflicting directions, and valuation multiples in a quiet decline. The most telling signal this week is in analyst activity, which has been unusually busy and split. Morgan Stanley maintained its Overweight rating but cut its target from $362 to $353 on April 23 — just one day after…
CME cost to borrow jumps 106% over the past week to 0.48%, rebounding sharply from a low of 0.23% on April 15th.
Snapshot as of 8 May 2026
CME Group heads into its May 14 Q1 results with the stock under pressure, analyst targets moving in conflicting directions, and valuation multiples in a quiet decline. The most telling signal this week is in analyst…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CME — free to start on ORTEX.
Sign up for free →Open CME on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live CME data →